Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study

Annals of Hematology · Published 2022-01-01 · Available online 3 Jan 2021 · Journal article · DOI 10.1007/s00277-020-04388-6 · Cited by 5 (Crossref)

Authors (6)

Satoshi Yamasaki, Takumi Matsushima, Mariko Minami, Masanori Kadowaki, Ken Takase, Hiromi Iwasaki

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume

101

Issue

1

Pages

209-211

Year

2022

Citation

Yamasaki, S., Matsushima, T., Minami, M., et al. (2022). Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study. Annals of Hematology. https://doi.org/10.1007/s00277-020-04388-6

Related articles

• First‐line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma · HemaSphere · 2026 · Cites or is cited by this article
• Posttransplant lymphoproliferative disorders following hematopoietic stem cell transplantation: a clinicopathological study of a large single-center cohort · Annals of Hematology · 2026 · Same journal
• Simultaneous onset of familial hemophagocytic lymphohistiocytosis and T-cell large granular lymphocytic leukemia in an adult · Annals of Hematology · 2026 · Same journal
• Angioimmunoblastic T-cell lymphoma following Castleman’s disease: diagnostic challenges and literature review · Annals of Hematology · 2026 · Same journal
• Single low-dose daratumumab enhances rituximab efficacy for sustained remission in treatment-refractory autoimmune cytopenias · Annals of Hematology · 2026 · Same journal
• Analysis of the diagnostic efficacy of hemoglobin capillary electrophoresis for thalassemia in children under 2 years old in Southern Fujian (Minnan) Region, China · Annals of Hematology · 2026 · Same journal
• Sea-blue histiocytosis and thrombocytopenia successfully treated with an mTORC1 inhibitor: a case report · Annals of Hematology · 2026 · Same journal
• 30 years in service, 1996–2026: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) · Annals of Hematology · 2026 · Same journal
• Sequential emergence of FLT3-ITD and BCR::ABL1 during disease progression in relapsed acute myeloid leukemia · Annals of Hematology · 2026 · Same journal
• A rare case of acute basophilic leukemia transformed from high risk myelodysplastic syndrome · Annals of Hematology · 2026 · Same journal

Metrics

Citations (Crossref)

5